Global Plastics in Personalized Drug Delivery Systems Market Size Study & Forecast, by Type, End Use, and Regional Forecasts 2025-2035

Description

The Global Plastics in Personalized Drug Delivery Systems Market is estimated to be valued at approximately USD 1.99 billion in 2024 and is projected to expand at a noteworthy CAGR of 10.79% over the forecast period from 2025 to 2035. Personalized medicine continues to radically transform the pharmaceutical industry, and at the heart of this revolution lies a dynamic interplay of engineering-grade polymers that are redefining drug delivery paradigms. Plastics such as PLA, PLGA, PEG, PU, and PEEK are increasingly being engineered with biocompatibility, controlled release, and degradation kinetics tailored to individual therapeutic needs. These materials form the backbone of highly efficient drug-eluting devices, smart capsules, microneedle arrays, and implantable reservoirs-creating precision vehicles that enable drugs to reach their targets with unmatched specificity and timed bioavailability.

As precision medicine gathers momentum, the need to deliver biologics, gene therapies, and patient-specific regimens safely and efficiently is amplifying the demand for performance plastics. Biodegradable materials like PLGA (Poly(lactic-co-glycolic acid)) and PEG (Polyethylene glycol) have become frontrunners in the development of nanoscale and depot-based delivery platforms, owing to their tunable mechanical properties, enzymatic sensitivity, and regulatory approval track records. Meanwhile, PEEK (Polyether ether ketone), a robust thermoplastic, is gaining traction in implant-based systems, especially where sustained drug elution is necessary in complex therapeutic environments. Innovations in polymer science, particularly at the intersection of AI-guided formulation and 3D printing, are enabling bespoke manufacturing of delivery systems at an unprecedented scale and precision.

From a regional perspective, North America maintains a dominant foothold, driven by a high concentration of biotech innovators, favorable reimbursement policies, and robust clinical trials for novel therapeutics. The U.S., in particular, is witnessing large-scale adoption of polymer-based delivery systems in oncology, endocrinology, and neurology. Europe follows with strong momentum, attributed to a maturing regulatory landscape favoring biodegradable and patient-centric devices, particularly in countries like Germany, Switzerland, and the Netherlands. Asia Pacific is poised for the fastest growth, led by China, India, and Japan, where expanding healthcare infrastructure, growing pharma manufacturing ecosystems, and rising patient awareness around personalized therapies are collectively propelling demand for advanced plastic-based systems in drug delivery.

Major market player included in this report are:

BASF SE
Evonik Industries AG
DuPont de Nemours Inc.
Celanese Corporation
SABIC
Solvay S.A.
Covestro AG
Eastman Chemical Company
Mitsubishi Chemical Group
RTP Company
Ensinger GmbH
Victrex plc
Arkema S.A.
Lubrizol Corporation
Rochling Group

Global Plastics in Personalized Drug Delivery Systems Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Type:

PLA
PLGA
PEG
PU
PEEK

By End Use:

Pharmaceuticals & Drug Delivery
Medical Devices & Implants
Healthcare & Clinics

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Plastics in Personalized Drug Delivery Systems Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top-Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global Plastics in Personalized Drug Delivery Systems Market Forces Analysis

3.1. Market Forces Shaping the Global Plastics in Personalized Drug Delivery Systems Market 2024-2035
3.2. Drivers
- 3.2.1. Surging Demand for Precision Medicine and Controlled-Release Platforms
- 3.2.2. Regulatory Push for Biocompatible and Biodegradable Polymers
3.3. Restraints
- 3.3.1. High Cost of Specialized Polymers and Manufacturing Complexity
- 3.3.2. Stringent Regulatory Approval Pathways and Quality Assurance Requirements
3.4. Opportunities
- 3.4.1. AI-Guided Formulation and 3D-Printed Personalized Devices
- 3.4.2. Expansion of Biologics and Gene Therapy Markets

Chapter 4. Global Plastics in Personalized Drug Delivery Systems Industry Analysis

4.1. Porter's Five Forces Model
- 4.1.1. Bargaining Power of Buyers
- 4.1.2. Bargaining Power of Suppliers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's Five Forces Forecast Model 2024-2035
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economic
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies 2025
4.6. Market Share Analysis 2024-2025
4.7. Global Pricing Analysis and Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Plastics in Personalized Drug Delivery Systems Market Size & Forecasts by Type 2025-2035

5.1. Market Overview
5.2. Performance Potential Analysis 2025
5.3. PLA
- 5.3.1. Top Countries' Estimates & Forecasts, 2024-2035
- 5.3.2. Market Size Analysis, by Region, 2025-2035
5.4. PLGA
- 5.4.1. Top Countries' Estimates & Forecasts, 2024-2035
- 5.4.2. Market Size Analysis, by Region, 2025-2035
5.5. PEG
- 5.5.1. Top Countries' Estimates & Forecasts, 2024-2035
- 5.5.2. Market Size Analysis, by Region, 2025-2035
5.6. PU
- 5.6.1. Top Countries' Estimates & Forecasts, 2024-2035
- 5.6.2. Market Size Analysis, by Region, 2025-2035
5.7. PEEK
- 5.7.1. Top Countries' Estimates & Forecasts, 2024-2035
- 5.7.2. Market Size Analysis, by Region, 2025-2035

Chapter 6. Global Plastics in Personalized Drug Delivery Systems Market Size & Forecasts by End Use 2025-2035

6.1. Market Overview
6.2. Performance Potential Analysis 2025
6.3. Pharmaceuticals & Drug Delivery
- 6.3.1. Top Countries' Estimates & Forecasts, 2024-2035
- 6.3.2. Market Size Analysis, by Region, 2025-2035
6.4. Medical Devices & Implants
- 6.4.1. Top Countries' Estimates & Forecasts, 2024-2035
- 6.4.2. Market Size Analysis, by Region, 2025-2035
6.5. Healthcare & Clinics
- 6.5.1. Top Countries' Estimates & Forecasts, 2024-2035
- 6.5.2. Market Size Analysis, by Region, 2025-2035

Chapter 7. Global Plastics in Personalized Drug Delivery Systems Market Size & Forecasts by Region 2025-2035

7.1. Market, Regional Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Market
- 7.3.1. U.S. Market
  - 7.3.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.3.1.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.3.2. Canada Market
  - 7.3.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.3.2.2. End-Use Breakdown Size & Forecasts, 2025-2035
7.4. Europe Market
- 7.4.1. UK Market
  - 7.4.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.1.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.4.2. Germany Market
  - 7.4.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.2.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.4.3. France Market
  - 7.4.3.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.3.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.4.4. Spain Market
  - 7.4.4.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.4.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.4.5. Italy Market
  - 7.4.5.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.5.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.4.6. Rest of Europe Market
  - 7.4.6.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.4.6.2. End-Use Breakdown Size & Forecasts, 2025-2035
7.5. Asia Pacific Market
- 7.5.1. China Market
  - 7.5.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.1.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.5.2. India Market
  - 7.5.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.2.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.5.3. Japan Market
  - 7.5.3.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.3.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.5.4. Australia Market
  - 7.5.4.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.4.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.5.5. South Korea Market
  - 7.5.5.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.5.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.5.6. Rest of Asia Pacific Market
  - 7.5.6.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.5.6.2. End-Use Breakdown Size & Forecasts, 2025-2035
7.6. Latin America Market
- 7.6.1. Brazil Market
  - 7.6.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.6.1.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.6.2. Mexico Market
  - 7.6.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.6.2.2. End-Use Breakdown Size & Forecasts, 2025-2035
7.7. Middle East & Africa Market
- 7.7.1. UAE Market
  - 7.7.1.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.7.1.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.7.2. Saudi Arabia Market
  - 7.7.2.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.7.2.2. End-Use Breakdown Size & Forecasts, 2025-2035
- 7.7.3. South Africa Market
  - 7.7.3.1. Type Breakdown Size & Forecasts, 2025-2035
  - 7.7.3.2. End-Use Breakdown Size & Forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. BASF SE
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Portfolio
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Evonik Industries AG
8.4. DuPont de Nemours Inc.
8.5. Celanese Corporation
8.6. SABIC
8.7. Solvay S.A.
8.8. Covestro AG
8.9. Eastman Chemical Company
8.10. Mitsubishi Chemical Group
8.11. RTP Company